| |
If you cannot view this e-mail correctly, please click here. |
|
| |
|
|
|
News from CEA´s European Projects
|
June, 20th 2017 |
|
|
02
|
|
|
|
|
| |
|
|
|
|
| |
|
|
|
Summary
|
|
|
|
|
|
| |
|
|
SOTERIA is improving safety of aging nuclear power plants
|
|
|
|
With HORSE, the industry rides advanced manufacturing technologies
|
|
|
|
From venoms to innovative drugs with VENOMICS
|
|
|
|
C-BORD helping customs to inspect containerised freight
|
|
|
|
LASERLAB-EUROPE, a broad-ranging cooperation on ultra-light and short-pulse laser infrastructure
|
|
|
|
| |
|
|
|
|
|
|
SOTERIA is improving safety of aging nuclear power plants
|
|
|
|
To ensure the safe long‐term operation of existing European nuclear power plants, the H2020 project SOTERIA proposes a comprehensive research approach in order to enable nuclear power plant operators, as well as regulators, to better understand and thereby predict the ageing phenomena occurring in reactor pressure vessels and internal steels.
SOTERIA aims to answer the key industrial issue of operating existing nuclear power plants beyond the originally anticipated time frame. (...)
|
|
|
|
|
|
|
|
|
|
|
|
|
With HORSE, the industry rides advanced manufacturing technologies
|
|
|
Together with major European industrial and academic partners, CEA, through its institute CEA LIST in Paris-Saclay, steps up its efforts to deploy advanced manufacturing technologies and robotics in industry.
Small and medium-sized companies form the backbone of the European economy. Ensuring that their production methods are state-of-the-art is key to maintaining competitiveness. Innovative technologies such as ollaborative robotics, smart vision systems, virtual and augmented reality and business process management tools are being developed by CEA (...) |
|
|
|
|
|
|
|
|
|
|
|
|
From Venoms to innovative Drugs with VENOMICS
|
|
|
|
Based on the study of two hundred poisonous animals, the European project VENOMICS managed to reproduce a bank of 3,616 “natural” toxins compatible with high throughput screening. As many as 280 active substances against diseases such as diabetes, obesity, inflammation and allergies were identified. VENOMICS demonstrated that animal toxins are hundred times more effective in identifying drug candidates than the usual banks of artificial molecules. R&D activities focusing on new therapeutic molecules have already started at CEA and in pharmaceutical laboratories. |
|
|
|
|
|
|
|
|
|
|
|
|
C-BORD helping customs to inspect containerised freight
|
|
|
Efficient non-intrusive inspection (NII) of containerised freight is critical for customs, as freight containers are potential means of smuggling, illegal immigration or even trafficking nuclear material and chemical warfare agents. A single NII technology cannot cope with all of these different threats. The C-BORD project’s objective is to address them all and enable customs to deploy comprehensive cost-effective solutions for the NII of containers in order to protect EU sea and land borders.
Efficient non-intrusive inspection (NII) of containerised freight is increasingly critical to trade and society, as the criminal (...)
|
|
|
|
|
|
|
|
|
|
|
|
|
LASERLAB-EUROPE, a broad-ranging cooperation on ultra-light and short-pulse laser infrastructure
|
|
|
CEA is working towards sharing and opening up laser and photonics infrastructure to European scientists. Today, Laserlab is an important tool for the development of laser metrology and laser-based instrumentation for a wide range of applications and societal needs in the fields of health, security, environment, etc. As one of the founding members of this community, CEA offers access to ultra-high intensity lasers with pulse duration in the femtosecond (10-15s) and attosecond (10-18s) ranges at the best level in Europe.
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
|
|
The French Alternative Energies and Atomic Energy Commission (CEA) is a public research organization working in four main areas: defense and security, nuclear and renewable energies, technological research for industry and fundamental research. Building on its recognized expertise, the CEA takes part in implementing cooperation projects with a wide range of academic and industrial partners. With its 16,000 researchers and employees, it is a major player in European research and is also expanding its international presence. More information: www.cea.fr/english
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
Contact
|
|
|
Guillaume Milot, Press officer
T. +33(0)1 64 50 14 88 | guillaume.milot@cea.fr
Commissariat à l'énergie atomique et aux énergies alternatives Centre de Saclay | Bâtiment Siège 447
91191 Gif-sur-Yvette Cedex - France
|
|
|
|
More
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
